Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer : A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials（2017） 文献来源：Journal of Clinical Oncology 2018